文献速递消化道肿瘤与早癌消化内镜

结直肠癌筛查项目影响的综合指标:晚期腺瘤目标人群率

Synthetic indicator of the impact of colorectal cancer screening programmes on incidence rates.
PubMed 文献 · Gut · 2019-04-30

研究提出「目标人群晚期腺瘤率」(AA-TAP)作为综合指标,反映筛查项目对结直肠癌(CRC)发病率的潜在影响。基于意大利2003至2016年全国筛查调查数据计算AA-TAP,并线性回归分析其与地区CRC发病率趋势的关联。结果显示2016年全国AA-TAP为105×100 000,南北地区差异显著;2004至2012年累积AA-TAP与2013-2014年相比2003-2004年CRC发病率差值显著相关(p=0.009)。

要点

  • AA-TAP定义为筛查项目中确诊晚期腺瘤人数除以项目目标人群。
  • 2016年意大利全国AA-TAP为105×100 000,北部和中部分别为126和149×100 000,南部及岛屿为36×100 000。
  • 2004至2012年累积AA-TAP与2013-2014年相比2003-2004年CRC发病率差值显著相关(p=0.009)。

核心结论

  • AA-TAP将筛查项目对降低CRC发病率的潜在影响综合为一个单一指标。

研究设计与样本

  • 基于意大利国家筛查调查2003至2016年数据,计算CRC筛查项目(每两年一次粪便免疫化学检测,目标人群50-69岁)的AA-TAP,并按地区分析。
  • 采用线性回归评估AA-TAP与50-74岁人群地区CRC发病率趋势的关联。

主要发现

  • 2016年意大利全国AA-TAP为105×100 000。
  • 北部和中部地区AA-TAP分别为126和149×100 000,南部及岛屿为36×100 000,地区间差异显著。
  • 2004至2012年累积AA-TAP与2013-2014年相比2003-2004年CRC发病率差值显著相关(p=0.009)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The impact of a screening programme on colorectal cancer (CRC) incidence in its target population depends on several variables, including coverage with invitations, participation rate, positivity rate of the screening test, compliance with an invitation to second-level assessment and endoscopists' sensitivity. We propose a synthetic indicator that may account for all the variables influencing the potential impact of a screening programme on CRC incidence. DESIGN: We defined the 'rate of advanced adenoma on the target population' (AA-TAP) as the rate of patients who received a diagnosis of advanced adenoma within a screening programme, divided by the programme target population. We computed the AA-TAP for the CRC Italian screening programmes (biennial faecal immunochemical test, target population 50-69 year olds) using the data of the Italian National Survey from 2003 to 2016, overall and by region, and assessed the association between AA-TAP and CRC incidence fitting a linear regression between the trend of regional CRC incidence rates in 50-74 year old subjects and the cumulative AA-TAP. RESULTS: In 2016, the AA-TAP at a national level was 105×100 000, whereas significant differences were observed between the northern and central regions (respectively 126 and 149×100 000) and the South and Islands (36×100 000). The cumulative AA-TAP from 2004 to 2012 was significantly correlated with the difference between CRC incidence rates in 2013-2014 and those in 2003-2004 (p=0.009). CONCLUSION: The AA-TAP summarises into a single indicator the potential impact of a screening programme in reducing CRC incidence rates.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Zorzi M, Zappa M. Synthetic indicator of the impact of colorectal cancer screening programmes on incidence rates. Gut. 2019. PMID: 31040168. doi:10.1136/gutjnl-2019-318589

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。